These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37 related articles for article (PubMed ID: 8862711)
1. Carboplatin in combination therapy for metastatic breast cancer. Perez EA Oncologist; 2004; 9(5):518-27. PubMed ID: 15477636 [TBL] [Abstract][Full Text] [Related]
2. Current options in treatment of anthracycline-resistant breast cancer. Kröger N; Achterrath W; Hegewisch-Becker S; Mross K; Zander AR Cancer Treat Rev; 1999 Oct; 25(5):279-91. PubMed ID: 10544072 [TBL] [Abstract][Full Text] [Related]
3. New approaches to breast cancer: oxaliplatin combined with 5-fluorouracil and folinic acid in pretreated advanced breast cancer patients: preliminary reports. Leonardi V; Savio G; Laudani A; Blasi L; Agostara B Ann N Y Acad Sci; 2002 Jun; 963():91-7. PubMed ID: 12095933 [TBL] [Abstract][Full Text] [Related]
4. New information on drug resistance: implications for the adjuvant treatment of breast cancer. Goldie JH Recent Results Cancer Res; 1989; 115():8-16. PubMed ID: 2696044 [TBL] [Abstract][Full Text] [Related]
5. The fluoropyrimidines: biochemical mechanisms and design of clinical trials. Friedman MA; Sadée W Cancer Chemother Pharmacol; 1978; 1(2):77-82. PubMed ID: 373913 [TBL] [Abstract][Full Text] [Related]
6. New options for the treatment of advanced ovarian cancer. Dunton CJ Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739 [TBL] [Abstract][Full Text] [Related]
7. Trastuzumab: new indication. Metastatic breast cancer, in combination with docetaxel: promising, but more evaluation is needed. Prescrire Int; 2006 Feb; 15(81):3-5. PubMed ID: 16548094 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer. Norton L Semin Oncol; 1999 Feb; 26(1 Suppl 3):1-4. PubMed ID: 10203263 [TBL] [Abstract][Full Text] [Related]
9. New approaches to the treatment of advanced breast cancer. Eckardt JR Anticancer Drugs; 1996 Aug; 7 Suppl 2():41-6. PubMed ID: 8862711 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review. Holmes FA Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900 [TBL] [Abstract][Full Text] [Related]
11. Evolving concepts in the systemic drug therapy of breast cancer. Norton L Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-3-S10-10. PubMed ID: 9275000 [TBL] [Abstract][Full Text] [Related]